Back
Atara Biotherapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
ATRA
Atara Biotherapeutics, Inc.
Last Price:
$4.94
Seasonality Move:
-3.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRA is experiencing slight selling pressure.
Atara Biotherapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.81 | Buy |
| 20-day SMA: | 5.36 | Sell |
| 50-day SMA: | 5.09 | Sell |
| 200-day SMA: | 10.73 | Sell |
| 8-day EMA: | 4.9 | Buy |
| 20-day EMA: | 5.1 | Sell |
| 50-day EMA: | 6.16 | Sell |
| 200-day EMA: | 9.5 | Sell |
Atara Biotherapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 46.73 | Sell |
| Chaikin Money Flow: | -18052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 6) | Sell |
| Bollinger Bands (100): | (4.17 - 14.75) | Sell |
Atara Biotherapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics, Inc. Stock
Is Atara Biotherapeutics, Inc. Stock a Buy?
-
Atara Biotherapeutics, Inc. share price is 4.99 while ATRA 8-day simple moving average is 4.81, which is a Buy signal.
-
The stock price of ATRA is 4.99 while Atara Biotherapeutics, Inc. 20-day SMA is 5.36, which makes it a Sell.
-
Atara Biotherapeutics, Inc. 50-day simple moving average is 5.09 while ATRA share price is 4.99, making it a Sell technically.
-
ATRA stock price is 4.99 and Atara Biotherapeutics, Inc. 200-day simple moving average is 10.73, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
31
Atara Biotherapeutics, Inc. (ATRA)
is a Sell
Is Atara Biotherapeutics, Inc. a Buy or a Sell?
-
Atara Biotherapeutics, Inc. stock is rated a SellThe current Atara Biotherapeutics, Inc. [ATRA] share price is $4.99. The Score for ATRA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics, Inc. Stock Info
Market Cap:
39M
Price in USD:
4.99
Share Volume:
46.9K
Atara Biotherapeutics, Inc. 52-Week Range
52-Week High:
19.15
52-Week Low:
3.92
Sell
31
Atara Biotherapeutics, Inc. (ATRA)
is a Sell
Atara Biotherapeutics, Inc. Share Price Forecast
-
What is the Atara Biotherapeutics, Inc. stock price today?The Atara Biotherapeutics, Inc. stock price is 4.99 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics, Inc. is overvalued.
Is Atara Biotherapeutics, Inc. Stock a Buy?
-
Atara Biotherapeutics, Inc. share price is 4.99 while ATRA 8-day exponential moving average is 4.90, which is a Buy signal.
-
The stock price of ATRA is 4.99 while Atara Biotherapeutics, Inc. 20-day EMA is 5.10, which makes it a Sell.
-
Atara Biotherapeutics, Inc. 50-day exponential moving average is 6.16 while ATRA share price is 4.99, making it a Sell technically.
-
ATRA stock price is 4.99 and Atara Biotherapeutics, Inc. 200-day simple moving average is 9.50, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics, Inc.
Is Atara Biotherapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.08 per share, and an increase next year of $1.10 per share.
Technical Analysis of Atara Biotherapeutics, Inc.
Should I short Atara Biotherapeutics, Inc. stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Atara Biotherapeutics, Inc. is a Sell
-
Atara Biotherapeutics, Inc. Relative Strength Index (RSI) is 46.73, which suggest Atara Biotherapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Atara Biotherapeutics, Inc. is (4.66 - 6), which suggest Atara Biotherapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Atara Biotherapeutics, Inc. is (4.17 - 14.75), which suggest Atara Biotherapeutics, Inc. is a Sell
* Atara Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.